153 related articles for article (PubMed ID: 4040179)
1. Development of nongerm cell malignancies in nonseminomatous germ cell tumors.
Ritchey ML; Bagnall JW; McDonald EC; Sago AL
J Urol; 1985 Jul; 134(1):146-9. PubMed ID: 4040179
[TBL] [Abstract][Full Text] [Related]
2. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
Loehrer PJ; Hui S; Clark S; Seal M; Einhorn LH; Williams SD; Ulbright T; Mandelbaum I; Rowland R; Donohue JP
J Urol; 1986 Jun; 135(6):1183-9. PubMed ID: 2423708
[TBL] [Abstract][Full Text] [Related]
3. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors.
Motzer RJ; Amsterdam A; Prieto V; Sheinfeld J; Murty VV; Mazumdar M; Bosl GJ; Chaganti RS; Reuter VE
J Urol; 1998 Jan; 159(1):133-8. PubMed ID: 9400455
[TBL] [Abstract][Full Text] [Related]
4. The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases.
Ulbright TM; Loehrer PJ; Roth LM; Einhorn LH; Williams SD; Clark SA
Cancer; 1984 Nov; 54(9):1824-33. PubMed ID: 6090001
[TBL] [Abstract][Full Text] [Related]
5. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
[TBL] [Abstract][Full Text] [Related]
6. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
Malagón HD; Valdez AM; Moran CA; Suster S
Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
[TBL] [Abstract][Full Text] [Related]
7. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
Jacqmin D
Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
[No Abstract] [Full Text] [Related]
8. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
9. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
Culine S
Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
[No Abstract] [Full Text] [Related]
10. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
[TBL] [Abstract][Full Text] [Related]
11. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyosarcoma in a patient treated for metastatic germ cell tumour of the testis containing teratoma--a case report.
Haines IE; Schwarz MA; Westmore DD; Sutherland RC
Aust N Z J Surg; 1985 Apr; 55(2):141-3. PubMed ID: 2412542
[TBL] [Abstract][Full Text] [Related]
13. Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapy.
Ahlgren AD; Simrell CR; Triche TJ; Ozols R; Barsky SH
Cancer; 1984 Nov; 54(9):2015-8. PubMed ID: 6478436
[TBL] [Abstract][Full Text] [Related]
14. The "growing teratoma syndrome" in primary mediastinal nonseminomatous germ cell tumors: criteria based on current practice.
Kesler KA; Patel JB; Kruter LE; Birdas TJ; Rieger KM; Okereke IC; Einhorn LH
J Thorac Cardiovasc Surg; 2012 Aug; 144(2):438-43. PubMed ID: 22713299
[TBL] [Abstract][Full Text] [Related]
15. [Bilateral and synchronous testicular teratoma: a case report and literature review].
Matabuena-Tamez P; Canepa-Fernández P; Valencia-García LC; Gutiérrez-Samperio C; Gallegos-Corona MA
Cir Cir; 2015; 83(6):527-31. PubMed ID: 26164135
[TBL] [Abstract][Full Text] [Related]
16. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
17. No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Monfardini S
J Urol; 1984 Apr; 131(4):677-80. PubMed ID: 6200611
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy in patients with teratoma with malignant transformation.
El Mesbahi O; Terrier-Lacombe MJ; Rebischung C; Theodore C; Vanel D; Fizazi K
Eur Urol; 2007 May; 51(5):1306-11; discussion 1311-2. PubMed ID: 17081678
[TBL] [Abstract][Full Text] [Related]
19. VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
Loehrer PJ; Einhorn LH; Williams SD
J Clin Oncol; 1986 Apr; 4(4):528-36. PubMed ID: 3633952
[TBL] [Abstract][Full Text] [Related]
20. [Effects of chemotherapy on regional metastases of non-seminomatous tumors of the testis].
Sakalo VS; Romanenko AM; Klimenko IA; Persidskiĭ IuV
Vopr Onkol; 1988; 34(10):1219-24. PubMed ID: 3188424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
